Skip to main content

First drug found to reduce mortality in hospitalised COVID-19 patients

The steroid dexamethasone has been identified as the first drug to improve survival rates in certain coronavirus patients, according to a study carried out by Queen Mary University of London and Barts Health NHS Trust, as part of a nationwide NIHR-funded clinical trial.

Published on:
Back to top